With the NMPA's approval, Mirxes will significantly scale up the commercialization of GASTROClear™ in China. The company ...

The non-invasive blood test helps in the early detection of the fifth leading cause of cancer deaths globally.

SAN ANTONIO, Aug. 5, 2025 /PRNewswire/ -- A groundbreaking multicenter clinical study published on July 30 in JAMA Surgery confirms the powerful diagnostic performance of the Destinex assay, a novel ...

A mouth rinse used to identify oral microbiome composition could serve as an early-detection tool for gastric cancer, new evidence suggests. Researchers found distinct bacterial composition ...

Please provide your email address to receive an email when new articles are posted on . Testing correctly identified 79% of patients with GI cancer as positive. Nearly all (96%) of healthy controls ...